Sub menu

 

 

Therapeutic Goods Administration (TGA)

We are Australia's government authority responsible for evaluating, assessing and monitoring products that are defined as therapeutic goods. We regulate medicines, medical devices and biologicals to help Australians stay healthy and safe.

Highlights

  • Image of the Xinyi Biyan Pills packaging

    Xinyi Biyan Pills

    Market actions
    Well Herb is recalling batch numbers: DB0014M & DB0015M with expiry Date 11/12/2027 supplied in Australia of Xinyi Biyan Pills due to the medicine having unacceptable amounts of lead above the permitted daily dose.
  • Counterfeit Rybelsus Semaglutide tablets

    Counterfeit Rybelsus Semaglutide tablets detected

    Safety alerts
    Consumers and health professionals should be aware that examples of counterfeit products have been stopped at the Australian border. These tablets may pose a serious risk to your health and should not be used.

Top tasks

Search for health products on our register

Search the Australian Register of Therapeutic Goods (ARTG) by name, ID or sponsor. Search results from the ARTG include Consumer Medicine Information (CMI) and Product Information (PI). Not all CMI and PI documents are available on this website.

 

 

Frequently searched by industry

Frequently searched by health professionals

Latest alerts

  • Counterfeit Botox vials detected

    Safety alerts
    Consumers and health professionals should be aware that two unrelated cases of counterfeit injectable botulinum toxin products have been stopped at the Australian border.

  • Xinyi Biyan Pills

    Market actions
    Well Herb is recalling batch numbers: DB0014M & DB0015M with expiry Date 11/12/2027 supplied in Australia of Xinyi Biyan Pills due to the medicine having unacceptable amounts of lead above the permitted daily dose.

  • Update on product correction A40/30 BiPAP Series

    Safety alerts
    Due to ongoing problems with their A30 and A40 series BiPAP devices, Philips is now contacting those affected to organise replacement devices or discuss alternative options.
All alerts

Latest news and updates

All news

Open consultations

All consultations